Drug comparisons
Exenatide vs Saxagliptin
Compare Exenatide (Byetta/Bydureon GLP-1 injection) vs Saxagliptin (Onglyza oral DPP-4) for type 2 diabetes: efficacy, weight loss, side effects, and CV risks.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered when selecting between an injectable GLP-1 receptor agonist and an oral DPP-4 inhibitor for type 2 diabetes after metformin.
Bottom line
Exenatide generally delivers superior glycemic control and weight reduction versus Saxagliptin, though oral convenience and differing safety profiles make the choice highly individual.
All medication comparisons